Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to -$3.6 million.

  • GoHealth's Net Cash Flow fell 11684.52% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.6 million, marking a year-over-year decrease of 13881.32%. This contributed to the annual value of -$49.8 million for FY2024, which is 16706.73% down from last year.
  • As of Q3 2025, GoHealth's Net Cash Flow stood at -$3.6 million, which was down 11684.52% from $13.2 million recorded in Q2 2025.
  • Over the past 5 years, GoHealth's Net Cash Flow peaked at $139.1 million during Q3 2022, and registered a low of -$199.0 million during Q4 2022.
  • In the last 5 years, GoHealth's Net Cash Flow had a median value of $880000.0 in 2023 and averaged -$5.9 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first crashed by 2564463.13% in 2022, then soared by 232988.64% in 2024.
  • Over the past 5 years, GoHealth's Net Cash Flow (Quarter) stood at -$773000.0 in 2021, then crashed by 25644.63% to -$199.0 million in 2022, then skyrocketed by 132.45% to $64.6 million in 2023, then tumbled by 91.61% to $5.4 million in 2024, then plummeted by 166.49% to -$3.6 million in 2025.
  • Its Net Cash Flow stands at -$3.6 million for Q3 2025, versus $13.2 million for Q2 2025 and -$18.6 million for Q1 2025.